GlassScriptPhysician profile
John J Land
NPI 1568548220
$3,506.29
in general payments reported to CMS, 2019-2025
11 companies · $26.08 in 2025
The $26.08 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $558 · 2020: $36.73 · 2021: $1,245 · 2022: $666 · 2023: $673 · 2024: $301 · 2025: $26.08.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,000.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $1,439.69 | 2019-2025 | Puraply, Cygnus Dual, Nushield |
| Alpha Orthopedic Systems | $1,200.00 | 2021 | |
| Smith+Nephew, INC. | $390.93 | 2019-2023 | Stravix Mesh, Grafix |
| Linvatec Corporation | $182.17 | 2023-2024 | Biobrace 23mm, Hall Power, Allograft Tissue |
| Osiris Therapeutics INC. | $82.75 | 2019 | |
| Abbvie INC. | $56.22 | 2022-2023 | |
| Polymedics Innovations INC. | $52.77 | 2023 | |
| Bioventus LLC | $48.14 | 2022-2023 | Sonicone Clinic |
| Allergan, INC. | $24.43 | 2020 | |
| Melinta Therapeutics, LLC | $17.33 | 2022 | |
| Acumed LLC | $11.86 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Land listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.